发明名称 |
ADJUVANT ADDITION TO IMMUNONANOTHERAPEUTIC AGENTS |
摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: group of inventions refers to medicine, namely to compositions and methods for nanocarrier delivery to the immune cells capable of stimulating an immune response in T-cells and/or B-cells. The composition contains polymer nanocarriers containing an immunofunctional surface formed of a collection of binding groups, wherein the collection is bound to dendritic cells or subcapsular sinus macrophages having higher avidity and lower affinity as compared to binding antibodies, and a pharmaceutically acceptable excipient. According to some versions, the immunostimulating group represents an adjuvant. The invention also concerns a method for administering the composition for T-cell proliferation in a patient.EFFECT: group of inventions enables the nanocarriers to deliver the immunomodulating and immunostimulating agents to B-cells and/or T-cells and to enhance the immune response of the system.35 cl, 20 ex, 40 dwg |
申请公布号 |
RU2496517(C2) |
申请公布日期 |
2013.10.27 |
申请号 |
RU20110118879 |
申请日期 |
2009.10.09 |
申请人 |
MASSACHUSETS INSTIT'JUT OF TEKNOLODZHI;PREZIDENT EHND FELLOUZ OF GARVARD KOLLEDZH;DZE BRIKHEHM EHND UIMEN'Z KHOSPITAL, INK. |
发明人 |
ALEKSIS FRANK;IANNAKONE MATTEO;SHI TSZIN'TSZJUN';BASTO PAMELA;MOUZMAN EHLLIOTT EHSHLI;VON ANDRIAN UL'RIKH;LANGER ROBERT;FAROKKHZAD OMID K.;TONTI ELENA |
分类号 |
A61K39/00;A61K38/19;B82Y5/00 |
主分类号 |
A61K39/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|